Safety and potency of BIV1‐CovIran inactivated vaccine candidate for SARS‐CoV‐2: A preclinical study

The development of effective and safe COVID‐19 vaccines is a major move forward in our global effort to control the SARS‐CoV‐2 pandemic. The aims of this study were (1) to develop an inactivated whole‐virus SARS‐CoV‐2 candidate vaccine named BIV1‐CovIran and (2) to determine the safety and potency o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Reviews in medical virology 2022-05, Vol.32 (3), p.e2305-n/a
Hauptverfasser:	Abdoli, Asghar, Aalizadeh, Reza, Aminianfar, Hossein, Kianmehr, Zahra, Teimoori, Ali, Azimi, Ebrahim, Emamipour, Nabbi, Eghtedardoost, Marzieh, Siavashi, Vahid, Jamshidi, Hamidreza, Hosseinpour, Mohammadreza, Taqavian, Mohammad, Jalili, Hasan
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antibodies, Neutralizing Antibodies, Viral BIV1‐CovIran Chlorocebus aethiops COVID-19 COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - adverse effects COVID-19 Vaccines - immunology Guinea Pigs Immune response immunisation Immunization Immunogenicity inactivated vaccine Macaca mulatta Mice Rabbits Review Reviews Safety SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Toxicity Trachea Vaccine Potency Vaccines Vaccines, Inactivated - adverse effects Vaccines, Inactivated - immunology Vero Cells Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!